T-SUPPRESSOR HYBRIDOMAS AND INTERLEUKIN-2-DEPENDENT LINES INDUCED BY COPOLYMER-1 OR BY SPINAL-CORD HOMOGENATE DOWN-REGULATE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

被引:84
作者
AHARONI, R [1 ]
TEITELBAUM, D [1 ]
ARNON, R [1 ]
机构
[1] WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL
关键词
SUPPRESSOR CELLS; AUTOIMMUNITY; IMMUNOMODULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALITIS;
D O I
10.1002/eji.1830230105
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Suppressor T (Ts) hybridomas and interleukin-2-dependent T cell lines were established from spleens of mice, which had been rendered unresponsive to experimental allergic encephalomyelitis (EAE) either by mouse spinal cord homogenate or by the synthetic suppressant copolymer 1 (Cop 1). The Ts hybridoma supernatants and the Ts line cells specifically suppressed the in vitro response to the encephalitogenic myelin basic protein (BP), as indicated by inhibition of both the proliferation and interleukin-2-secretion responses of a BP-specific T cell line. Moreover, these Ts cells prevented the development of actively induced EAE in vivo. All hybridomas and lines were most effective when injected at the time of disease induction, thus suggesting that they operate as effector suppressor cells, and functionally inhibit encephalitogenic responses. The data presented here suggest that the suppressor cells are stimulated by the protective epitopes included in the BP as well as in the Cop 1 molecules and that they play an active role in the regulation of EAE. The generation of Ts lines and hybridomas, which have been induced by Cop 1, establish the specific stimulation of suppressor cells to EAE as a mechanism underlying the therapeutic activity of Cop 1.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 45 条
[1]
EVIDENCE FOR SUPPRESSOR CELLS IN LEWIS RATS EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
ADDA, DH ;
BERAUD, E ;
DEPIEDS, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1977, 7 (09) :620-623
[2]
NEW PERSPECTIVES ON IMMUNOINTERVENTION IN AUTOIMMUNE-DISEASES [J].
ADORINI, L ;
BARNABA, V ;
BONA, C ;
CELADA, F ;
LANZAVECCHIA, A ;
SERCARZ, E ;
SUCIUFOCA, N ;
WEKERLE, H .
IMMUNOLOGY TODAY, 1990, 11 (11) :383-386
[3]
SUPPRESSOR CELL-FUNCTION IN MULTIPLE-SCLEROSIS - CORRELATION WITH CLINICAL-DISEASE ACTIVITY [J].
ANTEL, JP ;
ARNASON, BGW ;
MEDOF, ME .
ANNALS OF NEUROLOGY, 1979, 5 (04) :338-342
[4]
CELL-GROWTH CYCLE BLOCK OF T-CELL HYBRIDOMAS UPON ACTIVATION WITH ANTIGEN [J].
ASHWELL, JD ;
CUNNINGHAM, RE ;
NOGUCHI, PD ;
HERNANDEZ, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) :173-194
[5]
BENNUN A, 1983, J IMMUNOL, V130, P1205
[6]
THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS [J].
BENNUN, A ;
WEKERLE, H ;
COHEN, IR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) :195-199
[7]
BERNARD CCA, 1977, CLIN EXP IMMUNOL, V29, P100
[9]
A PILOT TRIAL OF COP-1 IN EXACERBATING REMITTING MULTIPLE-SCLEROSIS [J].
BORNSTEIN, MB ;
MILLER, A ;
SLAGLE, S ;
WEITZMAN, M ;
CRYSTAL, H ;
DREXLER, E ;
KEILSON, M ;
MERRIAM, A ;
WASSERTHEILSMOLLER, S ;
SPADA, V ;
WEISS, W ;
ARNON, R ;
JACOBSOHN, I ;
TEITELBAUM, D ;
SELA, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (07) :408-414
[10]
DORF ME, 1989, PROGR IMMUNOLOGY, V7, P875